Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 1014-1020, 2006. First published March 30, 2006; 10.1373/clinchem.2005.065052
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 065052.Suppl data file
Right arrow All Versions of this Article:
clinchem.2005.065052v1
52/6/1014    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valle, A.
Right arrow Articles by Whitfield, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valle, A.
Right arrow Articles by Whitfield, J. B.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2006;52:1014-1020.)
© 2006 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Butyrylcholinesterase: Association with the Metabolic Syndrome and Identification of 2 Gene Loci Affecting Activity

Anne Valle1, Daniel T. O’Connor1,2, Palmer Taylor1, Gu Zhu3, Grant W. Montgomery3, P. Eline Slagboom4, Nicholas G. Martin3 and John B. Whitfield3,5,a

Departments of1 Pharmacology and 2 Medicine, University of California at San Diego School of Medicine, and VA San Diego Healthcare System, La Jolla, CA.
3 The Queensland Institute of Medical Research, Brisbane, Australia.
4 Section of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
5 Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Sydney, Australia.

aAddress correspondence to this author at: Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. Fax 61-2-9515-7931; e-mail John.Whitfield{at}email.cs.nsw.gov.au.

Background: Plasma cholinesterase activity is known to be correlated with plasma triglycerides, HDL- and LDL-cholesterol, and other features of the metabolic syndrome. A role in triglyceride metabolism has been proposed. Genetic variants that decrease activity have been studied extensively, but the factors contributing to overall variation in the population are poorly understood. We studied plasma cholinesterase activity in a sample of 2200 adult twins to assess covariation with cardiovascular risk factors and components of the metabolic syndrome, to determine the degree of genetic effects on enzyme activity, and to search for quantitative trait loci affecting activity.

Methods and Results: Cholinesterase activity was lower in women than in men before the age of 50, but increased to activity values similar to those in males after that age. There were highly significant correlations with variables associated with the metabolic syndrome: plasma triglyceride, HDL- and LDL-cholesterol, apolipoprotein B and E, urate, and insulin concentrations; {gamma}-glutamyltransferase and aspartate and alanine aminotransferase activities; body mass index; and blood pressure. The heritability of plasma cholinesterase activity was 65%. Linkage analysis with data from the dizygotic twin pairs showed suggestive linkage on chromosome 3 at the location of the cholinesterase (BCHE) gene and also on chromosome 5.

Conclusions: Our results confirm and extend the connection between cholinesterase, cardiovascular risk factors, and metabolic syndrome. They establish a substantial heritability for plasma cholinesterase activity that might be attributable to variation near the structural gene and at an independent locus.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. B. Whitfield, V. Dy, P. A.F. Madden, A. C. Heath, N. G. Martin, and G. W. Montgomery
Measuring Carbohydrate-Deficient Transferrin by Direct Immunoassay: Factors Affecting Diagnostic Sensitivity for Excessive Alcohol Intake
Clin. Chem., July 1, 2008; 54(7): 1158 - 1165.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P.-a. B. Shih and D. T. O'Connor
Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity
Hypertension, June 1, 2008; 51(6): 1456 - 1464.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.